Development and Characterization of a Novel Peptide—Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors

por Wang, Yayu, Li, Yadan, Cao, Jieqiong, Meng, Qilin, Li, Xiaocen, Zhang, Yibo, Lam, Kit S., Hong, An, Liu, Ruiwu, Chen, Xiaojia
Publicado 2021

Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis

por Meng, Qilin, Luo, Lin, Lei, Minghua, Chen, Zhiqi, Sun, Yuanmeng, Chen, Xue, Zhai, Zhaodong, Zhang, Yibo, Cao, Jieqiong, Su, Zijian, Li, Fu, Li, Jingsheng, Hong, An, Chen, Xiaojia
Publicado 2023

Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway

por Jin, Yuan, Meng, Qilin, Zhang, Bihui, Xie, Chen, Chen, Xue, Tian, Baoqing, Wang, Jiakang, Shih, Tsung-Chieh, Zhang, Yibo, Cao, Jieqiong, Yang, Yiqi, Chen, Size, Guan, Xinyuan, Chen, Xiaojia, Hong, An
Publicado 2021

Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist

por Su, Zijian, Zhang, Yibo, Cao, Jieqiong, Sun, Yuanmeng, Cai, Yuling, Zhang, Bihui, He, Liu, Zhang, Zilei, Xie, Junye, Meng, Qilin, Luo, Lin, Li, Fu, Li, Jingsheng, Zhang, Jinting, Chen, Xiaojia, Hong, An
Publicado 2023

Turning gray selenium into a nanoaccelerator of tissue regeneration by PEG modification

por Cao, Jieqiong, Zhang, Yibo, Zhang, Peiguang, Zhang, Zilei, Zhang, Bihui, Feng, Yanxian, Li, Zhixin, Yang, Yiqi, Meng, Qilin, He, Liu, Cai, Yulin, Wang, Zhenyu, Li, Jie, Chen, Xue, Liu, Hongwei, Hong, An, Zheng, Wenjie, Chen, Xiaojia
Publicado 2022